Bharat Biotech seeks DCGI nod for study of intra-nasal COVID vaccine as booster dose Ruchika Sharma21 Dec 2021 12:00 PM ISTNew Delhi: Indian vaccine maker Bharat Biotech said on Monday it has submitted an application to the country's drug regulator to conduct a late-stage...
Bharat Biotech study on Covaxin, nasal COVID jab cocktail gets DCGI nod: Report Medical Dialogues Team13 Aug 2021 3:49 PM ISTHyderabad: In a significant advancement in Covid 19 vaccine development, Bharat Biotech has got approval from the Drug Controller General of India...
Bharat Biotech gets CDSCO panel nod to amend trial protocol of Adenoviral vector COVID vaccine Medical Dialogues Team2 April 2021 6:03 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has approved to amend Phase I...
CDSCO panel examines Bharat Biotech proposal for nasal vaccine trial for Covid-19 MD Bureau19 Jan 2021 4:34 PM ISTThe vaccine will be single-dosed.
Bharat Biotech to begin Phase 1 trials of intranasal vaccine for COVID-19 Ruchika Sharma8 Jan 2021 2:31 PM ISTAn intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes, etc., significantly...
